{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:16:10Z","timestamp":1792264570461,"version":"4.4.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.radonc.2024.110200","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T19:07:53Z","timestamp":1709406473000},"page":"110200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neurological complications of modern radiotherapy for head and neck cancer"],"prefix":"10.1016","volume":"194","author":[{"given":"James C.H.","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.S.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Man","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventure Y.M.","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Beitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primo\u017e","family":"Strojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti A.","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Eisbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweet Ping","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Nuyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Babighian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Ferlito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110200_b0005","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"398","author":"Mody","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110200_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9100135","article-title":"Can intensity-modulated-radiotherapy reduce toxicity in head and neck squamous cell carcinoma?","volume":"9","author":"van der Veen","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2024.110200_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3857\/roj.2020.00213","article-title":"Late side effects of radiation treatment for head and neck cancer","volume":"38","author":"Brook","year":"2020","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2024.110200_b0030","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2011.35.7301","article-title":"Population-based study of competing mortality in head and neck cancer","volume":"29","author":"Rose","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma","volume":"105","author":"Lee","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2020.07.037","article-title":"The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines","volume":"151","author":"Jensen","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13014-014-0264-9","article-title":"Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group","volume":"9","author":"Merlotti","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1259\/0007-1285-65-778-918","article-title":"Retrospective analysis of nasopharyngeal carcinoma treated during 1976\u20131985: late complications following megavoltage irradiation","volume":"65","author":"Lee","year":"1992","journal-title":"Brit. J. Radiol."},{"key":"10.1016\/j.radonc.2024.110200_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.oraloncology.2019.05.014","article-title":"Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer","volume":"95","author":"Dong","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0060","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamaoto.2018.1791","article-title":"Symptom burden associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors","volume":"144","author":"Aggarwal","year":"2018","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.radonc.2024.110200_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.12.004","article-title":"Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study)","volume":"77","author":"Au","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2019.06.011","article-title":"Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: clinical predictors and dose-toxicity relationship","volume":"138","author":"Chow","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0075","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/hed.24789","article-title":"Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: a cohort analysis and literature review","volume":"39","author":"Hutcheson","year":"2017","journal-title":"Head & Neck"},{"key":"10.1016\/j.radonc.2024.110200_b0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer\u2013success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijc.32099","article-title":"Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trial","volume":"145","author":"Li","year":"2019","journal-title":"Int. J. Can."},{"key":"10.1016\/j.radonc.2024.110200_b0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijrobp.2018.05.060","article-title":"Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy","volume":"102","author":"McDowell","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13014-023-02247-y","article-title":"Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis","volume":"18","author":"Xu","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106139","article-title":"Long-term results of the phase II dose and volume de-escalation trial for locoregionally advanced nasopharyngeal carcinoma","volume":"134","author":"Xue","year":"2022","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0110","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fonc.2020.00930","article-title":"Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors","volume":"10","author":"McDowell","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.meddos.2020.07.002","article-title":"Application of hypoglossal nerve constraint in definitive radiotherapy for nasopharyngeal carcinoma: a dosimetric feasibility study","volume":"46","author":"Chow","year":"2021","journal-title":"Med. Dosimetry"},{"key":"10.1016\/j.radonc.2024.110200_b0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CND.0b013e31820d4f20","article-title":"Delayed cervicobulbar neuronopathy and myokymia after head and neck radiotherapy for nasopharyngeal carcinoma: a case report","volume":"12","author":"Rison","year":"2011","journal-title":"J. Clin. Neuromuscular Disease"},{"key":"10.1016\/j.radonc.2024.110200_b0125","article-title":"Osteoradionecrosis of the temporal bone as a rare cause of facial nerve palsy","volume":"12","author":"Schmidt","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.radonc.2024.110200_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2022.980786","article-title":"Osteoradionecrosis of the jaw: a mini review","volume":"3","author":"Singh","year":"2022","journal-title":"Front Oral Health"},{"key":"10.1016\/j.radonc.2024.110200_b0135","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0140","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1002\/hed.24600","article-title":"High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy","volume":"39","author":"McDowell","year":"2017","journal-title":"Head & Neck"},{"key":"10.1016\/j.radonc.2024.110200_b0145","doi-asserted-by":"crossref","unstructured":"Dutta P, Dhandapani S, Kumar N, Gupta P, Ahuja C, Mukherjee KK. Bevacizumab for Radiation Induced Optic Neuritis Among Aggressive Residual\/Recurrent Suprasellar Tumors: More Than a Mere Antineoplastic Effect. World Neurosurg. 2017;107:1044 e1045-1044 e1010.","DOI":"10.1016\/j.wneu.2017.07.111"},{"key":"10.1016\/j.radonc.2024.110200_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijrobp.2011.11.019","article-title":"Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer","volume":"84","author":"Chen","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0155","first-page":"23","article-title":"The radiation dose tolerance of the brachial plexus: a systematic review and meta-analysis","volume":"18","author":"Yan","year":"2019","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1748-717X-8-173","article-title":"Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma","volume":"8","author":"Mutter","year":"2013","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00066-010-2099-0","article-title":"Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma","volume":"186","author":"Platteaux","year":"2010","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2024.110200_b0170","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/jcrt.JCRT_959_17","article-title":"Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapy","volume":"15","author":"Prakash","year":"2019","journal-title":"J. Can. Res. Therapeut."},{"key":"10.1016\/j.radonc.2024.110200_b0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/COC.0000000000000001","article-title":"Whole-field sequential intensity-modulated radiotherapy for local-regional advanced head-and-neck squamous cell carcinoma","volume":"38","author":"Refaat","year":"2015","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13014-015-0409-5","article-title":"Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy","volume":"10","author":"Thomas","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijrobp.2011.10.079","article-title":"Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage","volume":"84","author":"Truong","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0195","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2010.10.035","article-title":"Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer","volume":"82","author":"Yi","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0200","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1148\/rg.304095105","article-title":"Brachial plexus contouring with CT and MR imaging in radiation therapy planning for head and neck cancer","volume":"30","author":"Truong","year":"2010","journal-title":"Radiographics"},{"key":"10.1016\/j.radonc.2024.110200_b0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JCO.18.00896","article-title":"Effect of pregabalin on radiotherapy-related neuropathic pain in patients with head and neck cancer: a randomized controlled trial","volume":"37","author":"Jiang","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0215","doi-asserted-by":"crossref","first-page":"e2020202","DOI":"10.4322\/acr.2020.202","article-title":"Treatment of radiation-induced brachial plexopathy with omentoplasty","volume":"10","author":"de Oliveira","year":"2020","journal-title":"Autopsy Case Rep."},{"key":"10.1016\/j.radonc.2024.110200_b0220","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ijrobp.2009.08.078","article-title":"Radiation associated brainstem injury","volume":"76","author":"Mayo","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0225","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","article-title":"Radiation dose-volume effects in the spinal cord","volume":"76","author":"Kirkpatrick","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.oraloncology.2017.08.011","article-title":"Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma","volume":"73","author":"Li","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0235","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.04.032","article-title":"Evolution and dosimetric analysis of magnetic resonance imaging-detected brain stem injury after intensity modulated radiation therapy in nasopharyngeal carcinoma","volume":"105","author":"Huang","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-018-1015-0","article-title":"Identifying risk factors for L'hermitte's sign after IMRT for head and neck cancer","volume":"13","author":"Laidley","year":"2018","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/907960","article-title":"Lhermitte's sign developing after IMRT for head and neck cancer","volume":"2010","author":"Lim","year":"2010","journal-title":"Int. J. Otolaryngol."},{"key":"10.1016\/j.radonc.2024.110200_b0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00066-011-0010-2","article-title":"Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer","volume":"188","author":"Mul","year":"2012","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2024.110200_b0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hed.20140","article-title":"Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy","volume":"27","author":"Leung","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2024.110200_b0260","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/0003-4819-155-12-201112200-00005","article-title":"Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. preventive services task force","volume":"155","author":"Chung","year":"2011","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.radonc.2024.110200_b0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2012.07.005","article-title":"Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT phase III trial","volume":"104","author":"Gulliford","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2017.08.008","article-title":"Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy","volume":"126","author":"Ferris","year":"2018","journal-title":"Radiotherapy Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13014-020-01560-0","article-title":"Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy","volume":"15","author":"Wu","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0360-3016(97)00580-4","article-title":"Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma","volume":"40","author":"Lee","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0360-3016(03)00075-0","article-title":"Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation","volume":"56","author":"Kam","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0290","doi-asserted-by":"crossref","first-page":"e67488","DOI":"10.1371\/journal.pone.0067488","article-title":"Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One1"},{"key":"10.1016\/j.radonc.2024.110200_b0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1748-717X-8-17","article-title":"Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy","volume":"8","author":"Su","year":"2013","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0300","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1471-2407-13-397","article-title":"Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis","volume":"13","author":"Sun","year":"2013","journal-title":"BMC Can."},{"key":"10.1016\/j.radonc.2024.110200_b0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2014.05.036","article-title":"Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study","volume":"90","author":"Zhou","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/radiol.14141721","article-title":"Normal tissue complication probability model for radiation-induced temporal lobe injury after intensity-modulated radiation therapy for nasopharyngeal carcinoma","volume":"276","author":"Zeng","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2024.110200_b0315","doi-asserted-by":"crossref","first-page":"26378","DOI":"10.1038\/srep26378","article-title":"LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma","volume":"6","author":"Kong","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.radonc.2024.110200_b0320","first-page":"557","article-title":"Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma","volume":"7","author":"Feng","year":"2018","journal-title":"Can. Med."},{"key":"10.1016\/j.radonc.2024.110200_b0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.07.020","article-title":"Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients","volume":"85","author":"Lu","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13014-019-1229-9","article-title":"Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study","volume":"14","author":"Huang","year":"2019","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13014-019-1250-z","article-title":"Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy","volume":"14","author":"Wang","year":"2019","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2021.01.008","article-title":"Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: a large registry-based retrospective study from China","volume":"157","author":"Wen","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0345","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0350","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2012.06.012","article-title":"Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma","volume":"104","author":"Su","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101618","article-title":"Mortality of early treatment for radiation-induced brain necrosis in head and neck cancer survivors: a multicentre, retrospective, registry-based cohort study","volume":"52","author":"Pan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.radonc.2024.110200_b0360","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0365","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijrobp.2022.03.027","article-title":"Efficacy and safety of apatinib for radiation-induced brain injury among patients with head and neck cancer: an open-label, single-arm, phase 2 study","volume":"113","author":"He","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0370","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1212\/WNL.0b013e318295d71a","article-title":"Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration","volume":"80","author":"Balestrini","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.radonc.2024.110200_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109863","article-title":"Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: a systematic review","volume":"188","author":"Iyizoba-Ebozue","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0380","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2018.09.012","article-title":"A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy","volume":"131","author":"McDowell","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110143","article-title":"Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: a cross-sectional study","volume":"193","author":"Chow","year":"2024","journal-title":"Radiotherapy Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0390","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijrobp.2009.06.080","article-title":"Cognitive function before and after intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: a prospective study","volume":"77","author":"Hsiao","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0395","doi-asserted-by":"crossref","first-page":"20130474","DOI":"10.1259\/bjr.20130474","article-title":"Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"87","author":"Khodayari","year":"2014","journal-title":"Brit. J. Radiol."},{"key":"10.1016\/j.radonc.2024.110200_b0400","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1038\/s41598-017-03517-y","article-title":"The hippocampus sparing volume modulated arc therapy does not influence plan quality on locally advanced nasopharyngeal carcinoma patients","volume":"7","author":"Gu","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.radonc.2024.110200_b0405","doi-asserted-by":"crossref","first-page":"e90007","DOI":"10.1371\/journal.pone.0090007","article-title":"Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma","volume":"9","author":"Han","year":"2014","journal-title":"PLoS One1"},{"key":"10.1016\/j.radonc.2024.110200_b0410","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1200\/JCO.2003.07.080","article-title":"The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity","volume":"21","author":"Meyers","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0415","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0420","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2014.58.4508","article-title":"Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial","volume":"33","author":"Rapp","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0425","first-page":"476","article-title":"Implementing a cognitive behavioral intervention for patients with head and neck cancer","volume":"31","author":"Thilges","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2024.110200_b0430","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.2147\/OPTH.S219268","article-title":"Radiation retinopathy: detection and management strategies","volume":"15","author":"Sahoo","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.radonc.2024.110200_b0435","article-title":"Radiation-induced optical coherence tomography angiography retinal alterations in patients with nasopharyngeal carcinoma","volume":"7","author":"Li","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.radonc.2024.110200_b0440","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15071999","article-title":"Radiation-induced retinopathy and optic neuropathy after radiation therapy for brain, head, and neck tumors: a systematic review","volume":"15","author":"Kinaci-Tas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2024.110200_b0445","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2147\/OPTH.S263291","article-title":"Ocular complications after radiation therapy: an observational study","volume":"14","author":"Nuzzi","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.radonc.2024.110200_b0450","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4143\/crt.2021.575","article-title":"Radiation-induced ocular surface disorders and retinopathy: ocular structures and radiation dose-volume effect","volume":"54","author":"Akagunduz","year":"2022","journal-title":"Can. Res. Treat."},{"key":"10.1016\/j.radonc.2024.110200_b0455","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2021.05.013","article-title":"Update of the EPTN atlas for CT- and MR-based contouring in neuro-oncology","volume":"160","author":"Eekers","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0460","doi-asserted-by":"crossref","first-page":"3548706","DOI":"10.1155\/2021\/3548706","article-title":"Mechanism and protection of radiotherapy induced sensorineural hearing loss for head and neck cancer","volume":"2021","author":"Shi","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.radonc.2024.110200_b0465","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ijrobp.2009.04.096","article-title":"Radiation therapy and hearing loss","volume":"76","author":"Bhandare","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2023.103914","article-title":"Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer \u2013 A prospective study","volume":"44","author":"Apoorva","year":"2023","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.radonc.2024.110200_b0475","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/hed.25112","article-title":"Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population","volume":"40","author":"Chan","year":"2018","journal-title":"Head & Neck"},{"key":"10.1016\/j.radonc.2024.110200_b0480","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejca.2018.08.006","article-title":"Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK\/08\/004)","volume":"103","author":"Nutting","year":"2018","journal-title":"Eur. J. Can."},{"key":"10.1016\/j.radonc.2024.110200_b0485","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tranon.2015.10.003","article-title":"Sensorineural hearing loss after combined intensity modulated radiation therapy and cisplatin-based chemotherapy for nasopharyngeal carcinoma","volume":"8","author":"Wang","year":"2015","journal-title":"Translat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0490","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12013-014-9814-x","article-title":"Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy","volume":"69","author":"Wei","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.radonc.2024.110200_b0495","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/j.clon.2021.10.013","article-title":"Sensorineural hearing loss in nasopharyngeal carcinoma survivors in the modern treatment era \u2013 the early and late effects of radiation and cisplatin","volume":"34","author":"Yip","year":"2022","journal-title":"Clin. Oncol. (Royal College of Radiologists)"},{"key":"10.1016\/j.radonc.2024.110200_b0500","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/00016489.2019.1566778","article-title":"Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma","volume":"139","author":"Zhu","year":"2019","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1016\/j.radonc.2024.110200_b0505","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.07.034","article-title":"Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis","volume":"73","author":"Chan","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0510","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1200\/JCO.2005.05.0096","article-title":"Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study","volume":"24","author":"Low","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0515","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.radonc.2024.110200_b0520","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S1470-2045(23)00232-2","article-title":"Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2\u20133 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"24","author":"Liu","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0525","doi-asserted-by":"crossref","first-page":"20150052","DOI":"10.1259\/bjr.20150052","article-title":"SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy","volume":"88","author":"Gao","year":"2015","journal-title":"Brit. J. Radiol."},{"key":"10.1016\/j.radonc.2024.110200_b0530","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13014-021-01796-4","article-title":"Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma","volume":"16","author":"Lamaj","year":"2021","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0535","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/lary.28909","article-title":"Long-term outcomes of cochlear implantation in irradiated ears of nasopharyngeal carcinoma patients","volume":"131","author":"Huang","year":"2021","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.radonc.2024.110200_b0540","article-title":"Risk of CVD following radiotherapy for head and neck cancer: an updated systematic review and meta-analysis","volume":"12","author":"Lin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0545","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2019.09.025","article-title":"Radiotherapy can increase the risk of ischemic cerebrovascular disease in head and neck cancer patients: A Korean population-based cohort study","volume":"142","author":"Lee","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0550","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2016.07.007","article-title":"Stroke after radiation therapy for head and neck cancer: what is the risk?","volume":"96","author":"Arthurs","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0555","doi-asserted-by":"crossref","first-page":"1111764","DOI":"10.3389\/fonc.2023.1111764","article-title":"Stroke death in patients receiving radiation for head and neck cancer in the modern era","volume":"13","author":"Hardy","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0560","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00066-018-1304-4","article-title":"Radiation-induced carotid artery lesions","volume":"194","author":"Fernandez-Alvarez","year":"2018","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2024.110200_b0565","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/STROKEAHA.108.532218","article-title":"Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis","volume":"40","author":"de Weerd","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.radonc.2024.110200_b0570","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000363068","article-title":"Radiation-induced carotid artery stenosis: a comprehensive review of the literature","volume":"2","author":"Xu","year":"2014","journal-title":"Interv. Neurol."},{"key":"10.1016\/j.radonc.2024.110200_b0575","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3109\/02688697.2010.495171","article-title":"Balloon test occlusion with hypotensive challenge for main trunk occlusion of internal carotid artery aneurysms and pseudoaneurysms","volume":"24","author":"Wong","year":"2010","journal-title":"Brit. J. Neurosurg."},{"key":"10.1016\/j.radonc.2024.110200_b0580","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2021.01.026","article-title":"Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose","volume":"157","author":"van Aken","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0585","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/cncr.28938","article-title":"Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life","volume":"120","author":"Spencer","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110200_b0590","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijrobp.2017.01.018","article-title":"Re-evaluation of ipsilateral radiation for T1\u2013T2N0-N2b tonsil carcinoma at the Princess Margaret Hospital in the Human Papillomavirus era, 25 years later","volume":"98","author":"Huang","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0595","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1200\/JCO.19.00186","article-title":"Eliminating postoperative radiation to the pathologically node-negative neck: long-term results of a prospective phase II study","volume":"37","author":"Contreras","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0600","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/lary.27873","article-title":"Outcomes of carotid-sparing IMRT for T1 glottic cancer: comparison with conventional radiation","volume":"130","author":"Mohamed","year":"2020","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.radonc.2024.110200_b0605","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/j.jvs.2021.04.073","article-title":"Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease","volume":"75","author":"AbuRahma","year":"2022","journal-title":"J. Vascul. Surg."},{"key":"10.1016\/j.radonc.2024.110200_b0610","unstructured":"National Comprehensive Cancer Network. Head and neck cancer (version 2.2023). Retrieved from https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf."},{"key":"10.1016\/j.radonc.2024.110200_b0615","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/hed.24646","article-title":"Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy","volume":"39","author":"Okoye","year":"2017","journal-title":"Head & Neck"},{"key":"10.1016\/j.radonc.2024.110200_b0620","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5853\/jos.2017.01802","article-title":"Incidental statin use and the risk of stroke or transient ischemic attack after radiotherapy for head and neck cancer","volume":"20","author":"Addison","year":"2018","journal-title":"J Stroke"},{"key":"10.1016\/j.radonc.2024.110200_b0625","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/01.HYP.0000160355.93303.72","article-title":"Baroreflex failure","volume":"45","author":"Heusser","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.radonc.2024.110200_b0630","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.HYP.0000077441.45309.08","article-title":"Baroreflex failure as a late sequela of neck irradiation","volume":"42","author":"Sharabi","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.radonc.2024.110200_b0635","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mus.23530","article-title":"Long-term effects of neck irradiation on cardiovascular autonomic function: a study in nasopharyngeal carcinoma patients after radiotherapy","volume":"47","author":"Huang","year":"2013","journal-title":"Muscle & Nerve"},{"key":"10.1016\/j.radonc.2024.110200_b0640","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.radonc.2022.03.004","article-title":"Concurrent chemoradiation therapy is associated with an accelerated risk of cardiovascular autonomic dysfunction in patients with nasopharyngeal carcinoma: a 9-year prospective follow-up study","volume":"170","author":"Huang","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0645","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","article-title":"Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the international cardio-oncology society","volume":"3","author":"Mitchell","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.radonc.2024.110200_b0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/wjon996w","article-title":"Radiation-induced malignancies making radiotherapy a \u201ctwo-edged sword\u201d: a review of literature","volume":"8","author":"Singh","year":"2017","journal-title":"World J. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2023.101719","article-title":"Radiation-induced meningiomas (RIM) in adults: a single-Centre retrospective experience","volume":"3","author":"Banos","year":"2023","journal-title":"Brain Spine"},{"key":"10.1016\/j.radonc.2024.110200_b0660","article-title":"Radiotherapy-induced glioblastoma: distinct differences in overall survival, tumor location, pMGMT methylation and primary tumor epidemiology in Hong Kong chinese patients","volume":"1\u20138","author":"Woo","year":"2021","journal-title":"Brit. J. Neurosurg."},{"key":"10.1016\/j.radonc.2024.110200_b0665","first-page":"269","article-title":"Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries","volume":"18","author":"Scelo","year":"2007","journal-title":"Can. Causes Control"},{"key":"10.1016\/j.radonc.2024.110200_b0670","first-page":"1461","article-title":"Risk of second primary malignancies following nasopharyngeal carcinoma in Hong Kong","volume":"21","author":"Goggins","year":"2010","journal-title":"Can. Causes Control"},{"key":"10.1016\/j.radonc.2024.110200_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105012","article-title":"Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: a territory-wide study by HKNPCSG","volume":"111","author":"Chow","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0680","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S1470-2045(14)70268-2","article-title":"Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis","volume":"15","author":"Patel","year":"2014","journal-title":"The Lancet Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0685","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14338\/IJPT-20-00014.1","article-title":"Temporal lobe necrosis in head and neck cancer patients after proton therapy to the Skull Base","volume":"6","author":"Kitpanit","year":"2020","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2024.110200_b0690","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13014-023-02344-y","article-title":"Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers","volume":"18","author":"Liu","year":"2023","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2024.110200_b0695","doi-asserted-by":"crossref","first-page":"20190028","DOI":"10.1259\/bjr.20190028","article-title":"Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours","volume":"93","author":"Kountouri","year":"2020","journal-title":"Brit. J. Radiol."},{"key":"10.1016\/j.radonc.2024.110200_b0700","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/cncr.32938","article-title":"Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy","volume":"126","author":"Xiang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110200_b0705","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semradonc.2017.08.004","article-title":"Proton therapy for head and neck cancers","volume":"28","author":"Blanchard","year":"2018","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0710","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ijrobp.2021.01.041","article-title":"International recommendations on reirradiation by intensity modulated radiation therapy for locally recurrent nasopharyngeal carcinoma","volume":"110","author":"Ng","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0715","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0360-3016(01)01599-1","article-title":"Extent and kinetics of recovery of occult spinal cord injury","volume":"50","author":"Ang","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0720","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.04.021","article-title":"IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes","volume":"73","author":"Sulman","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2024.110200_b0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3857\/roj.2017.00122","article-title":"Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat. Oncol. J."},{"key":"10.1016\/j.radonc.2024.110200_b0730","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1470-2045(20)30673-2","article-title":"Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"22","author":"Liu","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2024.110200_b0735","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(23)00269-6","article-title":"Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial","volume":"401","author":"You","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110200_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104757","article-title":"Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: a meta-analysis and systematic review","volume":"107","author":"Lee","year":"2020","journal-title":"Oral Oncology"},{"key":"10.1016\/j.radonc.2024.110200_b0745","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2016.03.053","article-title":"Reirradiation of head and neck cancers with proton therapy: outcomes and analyses","volume":"96","author":"Phan","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:29:38Z","timestamp":1759123778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":149,"alternative-id":["S0167814024001221"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110200","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological complications of modern radiotherapy for head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110200"}}